Literature DB >> 22038553

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients.

Edoardo Savarino1, Patrizia Zentilin, Radu Tutuian, Daniel Pohl, Lorenzo Gemignani, Alberto Malesci, Vincenzo Savarino.   

Abstract

INTRODUCTION: Symptom association is important to distinguish non-erosive reflux disease [NERD; abnormal oesophageal acid exposure time (AET) and/or positive symptom association] from functional heartburn (FH; normal AET and negative symptom association). Asymptomatic patients during reflux monitoring are challenging as symptom association cannot be assessed. AIM: To evaluate whether impedance-pH reflux patterns are useful to differentiate NERD from FH.
METHODS: Endoscopy-negative reflux patients underwent impedance-pH off-therapy. Oesophageal AET, characteristics of reflux episodes and symptom association probability (SAP) were measured. Twenty patients asymptomatic during the first test repeated a second examination.
RESULTS: Of 329 patients, 130 (40%) were pH-POS, 120 (36%) pH-NEG/SAP+ (hypersensitive oesophagus = HO) and 79 (24%) pH-NEG/SAP- (FH). Total and acid reflux episodes were significantly higher (p < 0.01) in pH-POS compared to pH-NEG/SAP+, pH-NEG/SAP- and healthy volunteers (HVs). Patients pH-NEG/SAP+ had a significantly increased number of weakly acidic reflux episodes compared to pH-POS, pH-NEG/SAP- and HVs (p < 0.01). The rate of proximal reflux episodes in pH-POS (50%) and pH-NEG/SAP+ (47%) was higher (p < 0.01) than in pH-NEG/SAP- (33%) and HVs (33%). Measuring AET, number of reflux episodes and percentage of proximal reflux events permits to identify FH in 70% of cases and HO in 80% of cases who repeated the examination.
CONCLUSION: In patients with normal AET and SAP+, increased number of weakly acidic reflux and higher rate of proximal reflux are the main discriminant features. There is large overlap between FH and HVs. These differences can be of help in diagnosing patients with normal oesophageal acid exposure who fail to have symptoms during MII-pH testing.

Entities:  

Mesh:

Year:  2011        PMID: 22038553     DOI: 10.1007/s00535-011-0480-0

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

1.  Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".

Authors:  R G Watson; T C Tham; B T Johnston; N I McDougall
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  Increasing yield also increases false positives and best serves to exclude GERD.

Authors:  Jason Connor; Joel Richter
Journal:  Am J Gastroenterol       Date:  2006-03       Impact factor: 10.864

3.  Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.

Authors:  E Savarino; L Gemignani; D Pohl; P Zentilin; P Dulbecco; L Assandri; E Marabotto; D Bonfanti; S Inferrera; V Fazio; A Malesci; R Tutuian; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2011-06-14       Impact factor: 8.171

4.  Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group.

Authors:  Patrizia Zentilin; Vincenzo Savarino; Luca Mastracci; Paola Spaggiari; Pietro Dulbecco; Paola Ceppa; Edoardo Savarino; Andrea Parodi; Carlo Mansi; Roberto Fiocca
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

5.  Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.

Authors:  Edoardo Savarino; Radu Tutuian; Patrizia Zentilin; Pietro Dulbecco; Daniel Pohl; Elisa Marabotto; Andrea Parodi; Giorgio Sammito; Lorenzo Gemignani; Giorgia Bodini; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2009-12-08       Impact factor: 10.864

6.  Hiatal hernia is the key factor determining the lansoprazole dosage required for effective intra-oesophageal acid suppression.

Authors:  M Frazzoni; E De Micheli; A Grisendi; V Savarino
Journal:  Aliment Pharmacol Ther       Date:  2002-05       Impact factor: 8.171

7.  Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.

Authors:  S Emerenziani; D Sifrim; F I Habib; M Ribolsi; M P L Guarino; M Rizzi; R Caviglia; T Petitti; M Cicala
Journal:  Gut       Date:  2007-08-31       Impact factor: 23.059

8.  Impact of endoscopically minimal involvement on IL-8 mRNA expression in esophageal mucosa of patients with non-erosive reflux disease.

Authors:  Yusei Kanazawa; Hajime Isomoto; Chun-Yang Wen; Ai-Ping Wang; Vladimir A Saenko; Akira Ohtsuru; Fuminao Takeshima; Katsuhisa Omagari; Yohei Mizuta; Ikuo Murata; Shunichi Yamashita; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Differences in oesophageal bolus transit between patients with and without erosive reflux disease.

Authors:  C L Chen; C H Yi; I J Cook
Journal:  Dig Liver Dis       Date:  2008-03-04       Impact factor: 4.088

10.  Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD.

Authors:  K C Trimble; A Pryde; R C Heading
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

View more
  38 in total

1.  Data on Symptom Association Analysis in Patients Undergoing Endoscopic Therapy Is Useful to Better Define a Successful Therapeutic Approach.

Authors:  Salvatore Tolone; Manuele Furnari; Nicola de Bortoli; Edoardo Savarino
Journal:  Am J Gastroenterol       Date:  2015-11       Impact factor: 10.864

2.  Reply to "the importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing".

Authors:  Marzio Frazzoni; Micaela Piccoli; Rita Conigliaro; Raffaele Manta; Leonardo Frazzoni; Gianluigi Melotti
Journal:  Surg Endosc       Date:  2013-06-13       Impact factor: 4.584

3.  The importance of subgrouping refractory NERD patients according to esophageal pH-impedance testing.

Authors:  Edoardo Savarino; Maria Giacchino; Vincenzo Savarino
Journal:  Surg Endosc       Date:  2013-07-12       Impact factor: 4.584

4.  Symptom analysis improves GERD diagnosis and may be helpful to define a successful surgical approach.

Authors:  Nicola de Bortoli; Irene Martinucci; Santino Marchi; Edoardo Savarino
Journal:  Surg Endosc       Date:  2013-08-31       Impact factor: 4.584

5.  Non-erosive reflux disease patients are more complex than the sole endoscopy tells us.

Authors:  Andrea Ottonello; Vincenzo Savarino; Edoardo Savarino
Journal:  Clin Oral Investig       Date:  2013-08-09       Impact factor: 3.573

6.  Not all anti-reflux treatment failures are due to persistence of abnormal esophageal acid exposure.

Authors:  Manuele Furnari; Nicola de Bortoli; Vincenzo Savarino; Santino Marchi; Edoardo Savarino
Journal:  Surg Endosc       Date:  2013-10-26       Impact factor: 4.584

Review 7.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

8.  Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms.

Authors:  Daniela Jodorkovsky; Jennifer C Price; Brian Kim; Sameer Dhalla; Ellen M Stein; John O Clarke
Journal:  Dig Dis Sci       Date:  2014-02-23       Impact factor: 3.199

9.  Esophageal acid exposure still plays a major role in patients with NERD.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  J Gastroenterol       Date:  2013-02-05       Impact factor: 7.527

Review 10.  NERD: an umbrella term including heterogeneous subpopulations.

Authors:  Edoardo Savarino; Patrizia Zentilin; Vincenzo Savarino
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-26       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.